Skip to content

⚠️ Unlock Early Retirement with these Obesity Disrupting Stocks. 3 Best Stocks To Buy Now πŸš€πŸ’°

  • by
⚠️ Unlock Early Retirement with these Obesity Disrupting Stocks. 3 Best Stocks To Buy Now πŸš€πŸ’°

Video by Corns Investing via YouTube
Source
⚠️ Unlock Early Retirement with these Obesity Disrupting Stocks. 3 Best Stocks To Buy Now πŸš€πŸ’°

πŸ’°β˜…πŸ’°GRAB YOUR EARLY BLACK FRIDAY DEAL FOR SEEKING ALPHA SUBSCRIPTION HERE: https://www.sahg6dtr.com/37932Q/R74QP/

πŸ’°β˜…πŸ’° Follow us on Twitter: https://x.com/CornsInvesting

I share with you three of the best penny stocks to buy now – obesity stocks, Novo Nordisk (NVO), Eli Lilly (LLY), AstraZeneca plc (AZN) with huge catalysts for 2023 making them strong pharmaceutical stocks for 2023.

About 70 per cent of adults in the US and 64 per cent in the UK are obese or overweight, according to the FDA and the House of Commons library and this contributes to some of the most common causes of death, such as heart disease, stroke and diabetes.

The World Health Organization which describes obesity as a "rising epidemic" and estimates that more than 1 billion adults globally will be living with obesity in 2030. And the gems, I have for you today have FDA approved products to tackle obesity. And what really makes this opportunity and win win win is that, demand is significantly outstripping supply and these big players can’t make enough of the products. So a real opportunity here which is backed by tangible consumer demand driven by healthier life styles and the desire to look great from losing weight. Clearly something we can all connect to.

Novo Nordisk’s results have been impressive this year with sales of Wegovy totaling ($3 billion) and rising an incredible 481% during the first nine months of 2023. Ozempic is also growing at a fast rate of 53% and its sales are even higher, totaling ($9.2 billion). Overall, Novo Nordisk’s total revenue over the first three quarters of 2023 is up 29% while profits have risen at an even higher rate of 47% and so needless to say how good this growth has translated into their financials.

Novo Nordis is also about to get real competition. That’s because Eli Lily’s Tirzepatide will compete head on with Novo Nordisk’s Wegovy, which has come to dominate the market for weight-loss and diabetes management drugs with a 54.3 per cent global market share. Novo Nordisk has struggled to meet the demand for Wegovy, leaving many patients facing supply issues that have interrupted their treatment for a month at a time in some cases

So lots of catalysts lined up with these top stocks to buy now, giving them plenty of high growth upside and putting them amongst the best high growth stocks to buy now for 2023.

We have covered on the channel a range of ev battery and minerals penny stocks including. Nickel stocks, Lithium stocks, graphite stocks, cobalt stocks. Under a penny stock. Lithium penny stocks. Lithium-ion battery stocks. EV battery stocks. EV charging stocks. EV penny stocks. Below a penny stocks. Sub penny stocks such as Glencore, Xiantippe Resources, Sayona Mining, Lake Resources. Penny Stocks Penny Stocks Penny Stocks Penny Stocks. ASX Stocks, Best ASX Stocks, ASX Mining Stocks, Best Mining Stocks. Best EV stocks. Seeking Alpha. Simply Wall Street.

β˜…β˜…β˜…β˜…β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜…

πŸ’°β˜…πŸ’° Please SHARE this video: https://youtu.be/PJHjJOI7hzo

πŸ’°β˜…πŸ’° Please SUBSCRIBE: https://bit.ly/3wjoOq9

πŸ’°β˜…πŸ’° πŸ“§ Business Inquires: cornsinvesting@gmail.com

β˜…β˜…β˜…β˜…β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜… β˜…β˜…β˜…β˜…

DISCLAIMER: Please also note that Corns Investing’s content is practical guidance for financial education purposes only, on how to invest in the stock market and so you would need to do your own research. In no event will Corns Investing be liable for any loss or damage including, without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of Corns Investing content on YouTube. Corns Investing is not a financial adviser. All financial decisions made by the viewer should be done after doing their research and talking with a financial adviser or planner. Corns Investing’s video content may change over time, or become outdated or invalid. Thank you and Happy Investing from Corns Investing.

AFFILIATE DISCLOSURE: I only recommend products and services I truly believe in and use myself. Some of the links on this webpage are affiliate links, meaning, at no additional cost to you, I may earn a commission if you click through and make a purchase

Ignore:-

#obesity #wegovyweightloss #ozempicweightloss #stocks

obesity,Ozempic,Wegovy,nvo stock,novo stock,novo nordisk stock,wegovy stock,weight loss,weight loss stocks,Eli Lilly,lly stock,AstraZeneca,azn stock,ozempic stock,pharma stocks,corns investing,biotech stocks,Novo Nordisk,diabetes,diabetes stocks,obesity stocks,top stocks to buy now,growth stocks,best growth stocks,stocks to buy now,best stocks to buy now,best stocks 2023,best stocks to buy for 2023,best pharma stocks to buy,Best biotech stocks

obesity,Ozempic,Wegovy,nvo stock,novo stock,novo nordisk stock,wegovy stock,weight loss,weight loss stocks,Eli Lilly,lly stock,AstraZeneca,azn stock,ozempic stock,pharma stocks,corns investing,biotech stocks,Novo Nordisk,

Go to Source